Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

NCT00000331 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Heroin Dependence
Opioid-Related Disorders

Interventions

DRUG: Test Drug
DRUG: Placebo Drug

Sponsor

University of Colorado, Denver

Collaborators

[object Object]